These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2508137)

  • 1. [Critical analysis of antibiotic therapy of acute respiratory infections caused by Mycoplasma pneumoniae].
    Kuzman I; Petricević I
    Plucne Bolesti; 1989; 41(1-2):13-7. PubMed ID: 2508137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and epidemiologic features of acute respiratory infection caused by Mycoplasma pneumoniae].
    Kuzman I; Petricević I
    Lijec Vjesn; 1990; 112(7-8):216-21. PubMed ID: 2292893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute bronchitis in adults: commonly diagnosed but poorly defined.
    Leiner S
    Nurse Pract; 1997 Jan; 22(1):104, 107-8, 113-7; quiz 117-9. PubMed ID: 9004313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
    Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
    Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent.
    Atmar RL; Greenberg SB
    Semin Respir Infect; 1989 Mar; 4(1):19-31. PubMed ID: 2496449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
    Bartlett JG
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics: neither cost effective nor 'cough' effective.
    Hueston WJ
    J Fam Pract; 1997 Mar; 44(3):261-5. PubMed ID: 9071245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood.
    Schmidt SM; Müller CE; Gürtler L; Bruns R; Ballke EH; Wiersbitzky H; Ehlers M; Rose HJ; Wiersbitzky SK
    Klin Padiatr; 2005; 217(1):9-14. PubMed ID: 15640964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Respiratory pathology caused by Mycoplasma pneumoniae].
    Pescetti G; Gozzelino F
    Minerva Med; 1980 Dec; 71(49):3639-43. PubMed ID: 7454120
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.
    Principi N; Esposito S; Blasi F; Allegra L;
    Clin Infect Dis; 2001 May; 32(9):1281-9. PubMed ID: 11303262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Gillies MB; Chang AB
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis and laboratory diagnosis of Mycoplasma pneumoniae infections].
    Bébéar CM
    Arch Pediatr; 2008 Jul; 15(7):1253-6. PubMed ID: 18406582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Chang AB
    Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycoplasma pneumonia in young children, 2-5 years of age.
    Bunnag T; Lochindarat S; Srisan P; Jetanachai P
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S124-7. PubMed ID: 19253507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
    Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive empyema caused by Mycoplasma pneumoniae in an adult: a case report.
    Shuvy M; Rav-Acha M; Izhar U; Ron M; Nir-Paz R
    BMC Infect Dis; 2006 Feb; 6():18. PubMed ID: 16451727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae and Mycoplasma pneumoniae.
    Blasi F; Tarsia P; Aliberti S; Cosentini R; Allegra L
    Semin Respir Crit Care Med; 2005 Dec; 26(6):617-24. PubMed ID: 16388430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoplasma pneumoniae and community-acquired pneumonia.
    Dey AB; Chaudhry R; Kumar P; Nisar N; Nagarkar KM
    Natl Med J India; 2000; 13(2):66-70. PubMed ID: 10835852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should presumptive meningoencephalitis treatment in adults be active against Mycoplasma pneumoniae?].
    Trouillier S; Dionet E; Bocquier B; Constantin JM; Guelon D; Bonnet R; Romaszko JP; Laurichesse H; Beytout J; Lesens O
    Med Mal Infect; 2007 Nov; 37(11):738-45. PubMed ID: 17434700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.